CRISPR THERAPEUTICS

crispr-therapeutics-logo

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. They have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from their scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. CRISPR Therapeuticsโ€™ vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. The company is headquartered in Basel, Switzerland and has operations in London, UK.

#People #Financial #Event #Website #More

CRISPR THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Genetics Medical

Founded:
2013-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.crisprtx.com

Total Employee:
101+

Status:
Active

Contact:
141794589327

Email Addresses:
[email protected]

Total Funding:
127 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Nginx Microsoft Exchange Online



Current Advisors List

simeon-george_image

Simeon George Board Member @ CRISPR Therapeutics
Board_member

shaun-foy_image

Shaun Foy Board of Directors @ CRISPR Therapeutics
Board_member

rodger-novak_image

Rodger Novak Board of Directors @ CRISPR Therapeutics
Board_member

bradley-bolzon_image

Bradley Bolzon Board of Directors @ CRISPR Therapeutics
Board_member

tom-woiwode_image

Tom Woiwode Board of Directors @ CRISPR Therapeutics
Board_member

ali-behbahani_image

Ali Behbahani Board Member @ CRISPR Therapeutics
Board_member

Current Employees Featured

not_available_image

Stephen Kennedy
Stephen Kennedy Head Of Technical Operations @ CRISPR Therapeutics
Head Of Technical Operations

daniel-anderson_image

Daniel Anderson
Daniel Anderson Scientific Founders @ CRISPR Therapeutics
Scientific Founders

lawrence-klein_image

Lawrence Klein
Lawrence Klein Chief Operating Officer @ CRISPR Therapeutics
Chief Operating Officer
2016-01-01

doug-treco_image

Doug Treco
Doug Treco Director @ CRISPR Therapeutics
Director
2019-03-01

phuong-khanh-morrow_image

Phuong Khanh Morrow
Phuong Khanh Morrow chief medical officer @ CRISPR Therapeutics
chief medical officer
2022-05-01

chris-gemmiti_image

Chris Gemmiti
Chris Gemmiti Executive Director of Technical Operations @ CRISPR Therapeutics
Executive Director of Technical Operations
2020-11-01

emmanuelle-charpentier_image

Emmanuelle Charpentier
Emmanuelle Charpentier Co-Founder & Scientific Advisory Board Member @ CRISPR Therapeutics
Co-Founder & Scientific Advisory Board Member

rodger-novak_image

Rodger Novak
Rodger Novak Co-Founder & President @ CRISPR Therapeutics
Co-Founder & President
2017-12-01

craig-mello_image

Craig Mello
Craig Mello Scientific Founders @ CRISPR Therapeutics
Scientific Founders

not_available_image

Andrew Kernytsky
Andrew Kernytsky Senior Director, Head of Genomics and Computational Biology @ CRISPR Therapeutics
Senior Director, Head of Genomics and Computational Biology

Founder


chad-cowan_image

Chad Cowan

craig-mello_image

Craig Mello

daniel-anderson_image

Daniel Anderson

emmanuelle-charpentier_image

Emmanuelle Charpentier

matthew-porteus_image

Matthew Porteus

rodger-novak_image

Rodger Novak

shaun-foy_image

Shaun Foy

Stock Details


Company's stock symbol is NASDAQ:CRSP

Investors List

bill-melinda-gates-foundation_image

Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation investment in Grant - CRISPR Therapeutics

wellington-capital-management_image

Wellington Capital Management

Wellington Capital Management investment in Series B - CRISPR Therapeutics

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series B - CRISPR Therapeutics

clough-capital-partners_image

Clough Capital Partners

Clough Capital Partners investment in Series B - CRISPR Therapeutics

franklin-templeton-investments_image

Franklin Templeton Investments

Franklin Templeton Investments investment in Series B - CRISPR Therapeutics

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - CRISPR Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series B - CRISPR Therapeutics

sr-one_image

SR One

SR One investment in Series B - CRISPR Therapeutics

abingworth-management_image

Abingworth

Abingworth investment in Series B - CRISPR Therapeutics

vertex-pharmaceuticals_image

Vertex Pharmaceuticals

Vertex Pharmaceuticals investment in Series B - CRISPR Therapeutics

Official Site Inspections

http://www.crisprtx.com Semrush global rank: 315.99 K Semrush visits lastest month: 197.21 K

  • Host name: 64.62.152.250
  • IP address: 64.62.152.250
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "CRISPR Therapeutics" on Search Engine